Mounjaro Dosage in India: The Escalation Schedule Explained

Quick answer: Tirzepatide (Mounjaro) is a once-weekly injection that starts at a low dose and steps up gradually, typically over several months. The escalation exists to limit nausea and other gastrointestinal effects — it is not a delay to be shortcut. In SURMOUNT-1, the higher doses produced the largest weight reductions, up to around 20.9% at 72 weeks.

Why the dose starts low

The starting dose is not a treatment dose. It is a tolerance-building dose. GLP-1 and GIP receptor activation slows gastric emptying, and if you introduce that abruptly at a high dose, the result is nausea and vomiting severe enough that most people stop taking the medicine entirely.

Slow escalation is the single biggest determinant of whether someone is still on treatment at month six. The people who do best are almost never the ones who escalated fastest.

How escalation works in practice

The general pattern is a low starting dose held for about four weeks, then stepwise increases at roughly four-week intervals, continuing until you reach either the maximum dose or the lowest dose that is working well for you. Your actual schedule is set by your prescriber and may be slower than the standard pattern.

Two principles matter more than the specific numbers:

• You do not have to reach the maximum dose. If you are losing weight steadily and tolerating a middle dose well, staying there is a legitimate outcome, not a failure.
• Escalation can pause or step back. If a dose increase brings side effects you cannot manage, holding at the previous dose for longer is normal clinical practice.

Practical injection guidance

Pick one day of the week and keep it. Rotate injection sites between abdomen, thigh and upper arm rather than using the same spot repeatedly. If you miss a dose, do not double up — contact your care team, since the correct action depends on how long it has been.

Managing the escalation weeks

Nausea concentrates in the days after a dose increase. Smaller portions, eating slowly, stopping at comfortably full rather than finished, and easing off very rich or fried food during those days all help materially. Constipation is common too, and needs fluid and fibre attention early rather than after it becomes a problem.

Tell your care team about side effects rather than quietly enduring them. Most are manageable with adjustment, and the alternative — stopping abruptly — costs you the result.

What to do alongside the dose

Appetite suppression makes it easy to under-eat protein, and muscle is lost alongside fat when intake is low. Reviews of GLP-1 therapy consistently point to adequate protein and structured resistance training as the mitigations. Build both in from the first dose, not after you notice strength dropping.

The wider benefit

Tirzepatide's effects extend past the scale. It has been shown to improve obstructive sleep apnoea in people with obesity, and three-year SURMOUNT-1 data examined its effect on progression to type 2 diabetes in people with prediabetes. If any of those apply to you, they are worth raising with your doctor when you discuss dosing.